30-Second Takeaway
- AI-augmented confocal endomicroscopy can substitute for frozen section in brain tumor surgery with much faster turnaround.
- AI-driven MRI infiltration mapping in glioblastoma shows biologic validity and prognostic value for tailoring margins and radiotherapy.
- Most incidental meningiomas follow an indolent course, but molecularly hypermitotic subsets may merit earlier intervention.
- Evidence for thrombectomy in ACA, MeVO, and basilar occlusions is territory- and severity-dependent, refining endovascular thresholds.
- Modern series clarify indications and expected outcomes for EC–IC bypass, tentorial dAVF microsurgery, and MRgFUS thalamotomy in the elderly.
Week ending April 25, 2026
Practice-changing neurosurgical data: intraoperative AI, tumor risk stratification, cerebrovascular interventions, and functional procedures
AI-augmented confocal endomicroscopy rivals frozen section for rapid brain tumor diagnosis
In this multicenter prospective trial, confocal laser endomicroscopy (CLE) achieved non-inferior diagnostic accuracy to frozen section (0.94 vs 0.92). Sensitivity and specificity were similar, while CLE reduced median turnaround from 20 minutes to about 6 minutes. A Swin Transformer–based AI model reached 0.94 accuracy for tumor detection and 0.88 for biopsy subtype classification. These findings support CLE plus AI as a practical alternative or adjunct to frozen section for real-time intraoperative brain tumor decision-making.
Biopsy-controlled validation of an AI map of glioblastoma infiltration and recurrence risk
The SupraGlio trial prospectively validated GlioMap, an AI model predicting glioblastoma infiltration from multiparametric MRI. In 58 biopsies from 27 patients, the model achieved 0.81 accuracy and 0.84 AUC for histologically confirmed infiltration beyond enhancement. Transcriptomics showed a neural-to-mesenchymal gradient from low- to high-risk regions and core, supporting biological validity. Postoperative high-risk volume greater than 1.6 cm³ predicted shorter overall and progression-free survival. GlioMap thus offers a biologically grounded imaging biomarker that could guide extended resection and personalized radiotherapy targeting.
Incidental meningiomas generally behave indolently but include a higher-risk hypermitotic subset
This single-center cohort analyzed 238 incidental meningiomas with serial MRI and integrated molecular profiling. Symptoms developed in 15.5% of patients, and only 5% recurred after treatment, indicating generally favorable behavior. IMPACT groups effectively stratified treatment-free and symptom-free survival, supporting their use in surveillance planning. Most tumors were molecularly low risk, whereas Hypermitotic methylation-group lesions had higher IMPACT scores, suggesting need for closer monitoring or earlier intervention. Compared with 1434 non-incidental meningiomas, incidental tumors showed distinct molecular programs associated with favorable outcomes.
Thrombectomy for anterior cerebral artery occlusion improves 90-day outcomes without excess risk
This multicenter registry compared endovascular thrombectomy (EVT) with standard medical management for 343 anterior cerebral artery occlusion strokes within 24 hours. After inverse probability weighting, EVT improved 90-day modified Rankin distribution, excellent outcome, and functional independence versus medical therapy alone. Symptomatic intracranial hemorrhage and 90-day mortality did not differ significantly between EVT and medical management. Benefits were most evident in patients with baseline NIHSS ≥6, suggesting a severity threshold for intervention. These data support EVT as a reasonable option for ACA occlusions with moderate-to-severe deficits in experienced centers.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.